ANTIGEN MG7 IN GASTRIC CANCER AND GASTRIC PRECANCEROUS LESIONS

被引:0
|
作者
郭冬丽
宁佩芳
袁媛
机构
[1] The First Affiliated Hospital
[2] China Medical University Shenyang 110001
[3] China Medical University
[4] Cancer Institute
关键词
MG7; antigen; Gastric cancer; Gastric precancerous lesions; Diagnosis;
D O I
暂无
中图分类号
R735.2 [胃肿瘤];
学科分类号
摘要
Objective: To study the dynamic change and its diagnostic significance of MG7 expression in the process of gastric cancer development. Methods: The expression level of antigen MG7 was determined by immunohistochemistry method in 406 cases of gastric mucosa. The classification of intestinal metaplasia of gastric mucosa was determined by histochemistry method in 82 cases. Results: The positive rate of MG7 expression in normal gastric mucosa, intestinal metaplasia and dysplasia of gastric mucosa and gastric cancer were increased gradually (P<0.01). The positive rate of MG7 expression in superficial gastritis, atrophic gastritis and gastric cancer were increased on sequence (P<0.01). The positive rate of antigen MG7 expression in type III intestinal metaplasia of gastric mucosa had significant difference, compared with that in type I an II intestinal metaplasia (P<0.05). Conclusion: MG7 antigen had close relationship with gastric cancer. Type III intestinal metaplasia, atrophic gastritis and dysplasia should be followed up in order to improve the early detection of gastric cancer. MG7 antigen had great clinical value in the dynamic follow-up of gastric precursors.
引用
收藏
页码:4 / 7
页数:4
相关论文
共 50 条
  • [31] Recent progress in researches on precancerous lesions of gastric cancer in China
    Li, CQ
    Zhang, XR
    Liu, WW
    CHINESE MEDICAL JOURNAL, 1996, 109 (05) : 407 - 410
  • [32] Expression of Oncostatin M in Early Gastric Cancer and Precancerous Lesions
    Shi, Jihua
    Xu, Xue
    Du, Jun
    Cui, Haimeng
    Luo, Qingfeng
    GASTROENTEROLOGY RESEARCH AND PRACTICE, 2019, 2019
  • [33] Treatment of gastric precancerous lesions with Weiansan
    Hui-Zhen Li
    World Journal of Gastroenterology, 2006, (33) : 5389 - 5392
  • [34] Gastric precancerous lesions - Part 2
    Kandulski, A.
    Selgrad, M.
    Malfertheiner, P.
    DIGESTIVE AND LIVER DISEASE, 2008, 40 (08) : 619 - 626
  • [35] GENETIC ALTERATIONS IN GASTRIC PRECANCEROUS LESIONS
    Karaman, A.
    Kabalar, M. Esref
    Binici, D. Nasir
    Ozturk, C.
    Pirim, I.
    GENETIC COUNSELING, 2010, 21 (04): : 439 - 450
  • [36] EPIDEMIOLOGY OF PRECANCEROUS GASTRIC-LESIONS
    YOU, WC
    CHANG, YS
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1993, 8 (04) : 375 - 382
  • [37] Traditional Chinese medicine for precancerous lesions of gastric cancer: A review
    Xu, Weichao
    Li, Bolin
    Xu, Miaochan
    Yang, Tianxiao
    Hao, Xinyu
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 146
  • [38] The role of ras gene mutation in gastric cancer and precancerous lesions
    Hao Ying
    Zhang Jinkun
    Lu Youyong
    Yi Cuiqiong
    Qian Wei
    Cui Jiantao
    Current Medical Science, 1998, 18 (3) : 141 - 144
  • [39] The Role of Ras Gene Mutation in Gastric Cancer and Precancerous Lesions
    郝莹
    张锦刊
    吕有勇
    易粹琼
    钱伟
    崔建涛
    JournalofTongjiMedicalUniversity, 1998, (03) : 141 - 144
  • [40] Microsatellite instability in gastric precancerous lesions
    Stepanchenko, M.
    Shimanskaya, A.
    Kononov, A.
    Mozgovoi, S.
    Rubtsov, V.
    Parygina, M.
    Pomorgailo, E.
    VIRCHOWS ARCHIV, 2024, 485 : S160 - S161